Securities Class Action

Securities fraud litigation history and active cases

In Litigation

0

Settlement

0

Closed

1

Total Settlement

$0

NRX Pharmaceuticals, Inc. (NRXP) Class Action Lawsuit (January 2022)

Closed

1:22cv66 • January 18, 2022

Class Period Start

June 1, 2021

Class Period End

November 4, 2021

PSLRA Deadline

March 21, 2022

Case Allegations

10b5

Statutes of Repose

Jun 1, 2024

Country

United States

Court

Federal Court

Docket History

Jun 13, 2022

Voluntary Dismissal (opens in a new tab)

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Apr 6, 2022

Appointment of Lead Plaintiff (opens in a new tab)

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Jan 18, 2022

First Filed Complaint (opens in a new tab)

A securities fraud class action complaint has been filed on behalf of certain investors in NRX Pharmaceuticals, Inc..